sur Neurocare Group
Neurocare Group Announces Kevin Reeder as New CFO
Neurocare Group AG, a platform focused on mental health and performance, has appointed Kevin Reeder as Chief Financial Officer, effective January 1, 2025. Previously, Reeder was the CEO of the venture capital firm bm|t, a major investor in neurocare. His career spans international investment management, including roles at INVESCO, Silvergate Capital, and M-KOPA in Africa.
Reeder joined neurocare's board in 2021, influencing fundraising and strategic direction. He leaves the board to focus on CFO duties, aimed at enhancing the company's financial strategy and growth. Tristan de Boysson, Supervisory Board Chairman, praised Reeder's leadership and knowledge of neurocare's objectives.
Founder and CEO Thomas Mechtersheimer expressed confidence in Reeder's potential to accelerate the company's growth. Reeder acknowledged his new role with enthusiasm, highlighting the company's commitment to advancing mental health solutions.
R. P.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Neurocare Group